Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study

被引：0
|
作者：
Chunan Bian
Zhongyou Li
Youtao Xu
Jie Wang
Lin Xu
Hongbing Shen
机构：
[1] Nanjing Medical University-Affiliated Cancer Hospital,Department of Thoracic Surgery
[2] Jiangsu Key Laboratory of Molecular and Translational Cancer Research,undefined
[3] Nanjing Jiangbei Peoples’ Hospital,undefined
[4] The Public Health College of Nanjing Medical University,undefined
来源：
World Journal of Surgical Oncology | / 13卷
关键词：
Lung adenocarcinoma; Mutant ; Immunohistochemistry; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder
    Alexander, R. E.
    Richey, J. D.
    Williamson, S. R.
    Lopez-Beltran, A.
    Montironi, R.
    Davidson, D. D.
    Idrees, M. T.
    Jones, C. L.
    Zhang, S.
    Wang, L.
    Rao, Q.
    MacLennan, G. T.
    Cheng, L.
    LABORATORY INVESTIGATION, 2014, 94 : 213A - 213A
  • [32] P16、P53和SMAD4蛋白在胰腺癌组织中的表达及其临床意义
    张顺
    相亭海
    李玉军
    青岛大学医学院学报, 2006, (02) : 135 - 136+139
  • [33] Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer
    Jeong, J
    Park, YN
    Park, JS
    Yoon, DS
    Chi, HS
    Kim, BR
    YONSEI MEDICAL JOURNAL, 2005, 46 (04) : 519 - 525
  • [34] Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer
    Nwachukwu, Chika R.
    Harris, Jeremy P.
    Chin, Alex
    Von Eyben, Rie
    Giaretta, Stephanie
    Shaffer, Jenny L.
    Hiniker, Susan M.
    Kapp, Daniel S.
    Folkins, Ann K.
    Kidd, Elizabeth A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (06) : 588 - 596
  • [35] Expression of HMGA2, p16, and p53 in Gallbladder Lesions
    Lehrke, H.
    Wu, T-T
    Sarah, J.
    Mounajjed, T.
    LABORATORY INVESTIGATION, 2014, 94 : 190A - 190A
  • [36] Expression of HMGA2, p16, and p53 in Gallbladder Lesions
    Lehrke, H.
    Wu, T-T
    Sarah, J.
    Mounajjed, T.
    MODERN PATHOLOGY, 2014, 27 : 190A - 190A
  • [37] Immunohistochemistry of p16 and p53 in vulvar cancer
    Florencia Falcon, Maria
    Eugenia Paradeda, Maria
    Garcia Kamermann, Florencia
    Maldonado, Veronica
    Diaz, Lili
    Cardinal, Lucia
    MEDICINA-BUENOS AIRES, 2020, 80 (02) : 127 - 133
  • [38] Immunohistochemistry of P16 and P53 in vulvar cancer
    Lewkowicz, M. D. L. M.
    Paradeda, M. E.
    Gomez Cherey, F.
    Falcon, M. F.
    Garcia Kammermann, F.
    Sciaccaluga, D.
    Maldonado, V.
    Palaoro, L.
    Diaz, L.
    Cardinal, L.
    VIRCHOWS ARCHIV, 2020, 477 : S68 - S69
  • [39] Combine effect of P53 protein expression with P16 and P14 in survival outcome of breast cancer patients
    Pare, R.
    Shin, J. S.
    Lee, C. S.
    BREAST, 2017, 32 : S102 - S102
  • [40] Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas
    Carneiro, Fabiana Pirani
    Ramalho, Leandra Naira Zambelli
    Britto-Garcia, Sergio
    Ribeiro-Silva, Alfredo
    Zucoloto, Sergio
    DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 588 - 594
12345